// App-Quantinova.ai

Tu1391 : Is It Really Needed to Discontinue Antiplatelet Agents (APA) Prior to EUS-FNA Performance?: a Prospective Comparative Study

Researchers

Presenter

  • Enrique Vázquez Sequeiros

Principal Investigators

  • Fernando González-Panizo Tamargo

  • José Ramón Foruny

  • Victor defarges Pons

  • Carmen Gonzalez-Garcia

  • Juan Angel Gonzalez-Martin

  • Diego Juzgado

  • Daniel Boixeda-Miquel

  • Agustin Albillos

Medical Centers

  • Hematology, Hospital Ramon y Cajal, Madrid, Spain

  • Gastroenterology Unit, Hospital Ramon y Cajal, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Pancreatitis

  • Venous thrombosis

  • Coronary Artery Disease

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved